In vivo dosimetry in pelvic brachytherapy

This paper describes the potential role for in vivo dosimetry in the reduction of uncertainties in pelvic brachytherapy, the pertinent factors for consideration in clinical practice, and the future potential for in vivo dosimetry in the personalisation of brachytherapy. The EU Horizon 2020 Origin project is working to address the current barriers to the clinical implementation of in vivo dosimetry and to develop a real-time system based on optical fibre-based sensing technology for use in prostate and gynaecological brachytherapy.